Cell Therapy Manufacturing Market
Analysis of the Cell Therapy Manufacturing Market by Autologous and Allogenic
Discover How Programmable Cell Therapies Can Help Mankind to Fight Genetic Conditions like Sickle Cell Anemia in FMI's Report!
Cell Therapy Manufacturing Market Outlook (2023 to 2033)
The global cell therapy manufacturing market size is expected to reach a valuation of US$ 4,134.48 million in 2023 and further expand at a CAGR of 14.2% from 2023 to 2033. The market is anticipated to reach a valuation of ~US$ 15,634.67 million by the end of 2033. Autologous cell therapy manufacturing is leading the global market and held a share of about 56.0% in 2021.
A sophisticated gene-edited cell-based product such as chimeric antigen receptor (CAR)-T cells or tissue engineering products like Holoclar are examples of modern cell therapies that include but are not limited to blood transfusion and hematopoietic progenitor stem cell transplantation exclusively. Quality standards have evolved in response to the continual improvement of cell therapy manufacturing processes, thereby resulting in improved product consistency, reliability, and efficacy.
Manufacturing processes need a transition from open and manual to closed and automated in order to scale up. This offers several benefits such as decreased risk of contamination, improved product uniformity, increased efficiency, and surging traceability throughout the process to assure the chain of custody.
In order to reduce risks and get ready for a high-production future, groups in both academia and industry are actively implementing novel technologies that help them build automated, scalable, and closed systems. Key players are also working on the development of innovative technologies that assist investigators in automating their processes for success in the future.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Top Trend Pushing Sales in the Global Cell Therapy Manufacturing Industry
- Rising Practice of Manufacturing Capability Outsourcing
It is challenging and time-consuming for businesses that are not familiar with the cell therapy manufacturing process to build a solid supply chain with the tools and processes required to satisfy consumer demand.
Companies that have a strong understanding of the biology of their product, but are unfamiliar with how to transition from a small, manual production to a scaled-up, automated production that serves the needs of hundreds of thousands of patients globally, quickly bridge the gap with the help of an outside organization, such as a contract manufacturing organization (CMO).
Outsourcing of manufacturing capabilities creates growth opportunities for new industry entrants to scale up their products for wide-scale distribution. Additionally, outsourcing saves manufacturers from making investments in large-scale systems and facilitates anticipation of future product delays or regulatory denials.
Which Factors Are Limiting Demand in the Cell Therapy Manufacturing Industry?
Manufacturers of cell therapies face certain process limitations when they aim to provide a functional and safe output from an extremely variable starting material. Increased starting material variability poses limitations on the production protocols for desired end use products.
Additionally, as different phases in the production of cell therapy require variable timespans, bottlenecks develop in a fully automated system by holding one part of equipment engaged for a longer duration of time, while the rest of the system sits idle, not utilizing resources and wasting both time & space.
The design is more efficient in a modular system as only one part of the system is engaged and the rest of the system is available for usage. Another drawback of fully automated systems is that they could bind an organization or a research team to a certain methodology.
| Attributes | Details |
|---|---|
|
Cell Therapy Manufacturing Market CAGR (2023 to 2033) |
14.2% |
|
Cell Therapy Manufacturing Market Size (2023) |
US$ 4,134.48 million |
|
Cell Therapy Manufacturing Market Size (2033) |
US$ 15,634.67 million |
Sabyasachi Ghosh
Principal Consultant
Talk to Analyst
Find your sweet spots for generating winning opportunities in this market.
2018 to 2022 Cell Therapy Manufacturing Demand Outlook Compared to 2023 to 2033 Forecast
The cell therapy manufacturing industry held approximately 3.3% of the global targeted therapeutics market, which was worth ~US$ 3,685.7 million in 2022. The global cell therapy manufacturing market expanded at a CAGR of 10.7% from 2018 to 2022 owing to the positive outcomes of immunotherapy.
In its most precise definition, cell therapy manufacturing starts with the patient's cell collection in a clinical (or apheresis) facility and ends with the patient receiving the finished drug at their bedside. Numerous hand-off points and activities occur between the initial raw material collection and the subsequent administration of a product.
Cell therapy manufacturing differs from more conventional pharmaceutical production due to the complexity of all these working components in a supply chain, as well as the blend of the production and delivery phases. The majority, if not all, cell therapies currently available are only meant to treat a small number of patients.
However, if they are to be made widely accessible for a variety of indications, advancements in automation, process simplification, and supply chain management are necessary to keep up with the rising demand. Owing to the aforementioned factors, the global market is expected to surge at a CAGR of 14.2% during the forecast period.
Comparative View of the Market
Cell Therapy Manufacturing Market:
| Attributes | Cell Therapy Manufacturing Market |
|---|---|
|
CAGR (2023 to 2033) |
14.2% |
|
Market Value (2033) |
US$ 15,634.67 million |
|
Growth Factor |
Rising prevalence of sickle cell disease |
|
Opportunity |
Manufacturers focus on automation |
|
Key Trends |
Introduction new processing methods |
Stem Cell Therapy Market:
| Attributes | Stem Cell Therapy Market |
|---|---|
|
CAGR (2023 to 2033) |
16.7% |
|
Market Value (2033) |
US$ 1,182.06 million |
|
Growth Factor |
Expanding research in stem cell |
|
Opportunity |
Rising demand for innovative medicines |
|
Key Trends |
Rise in public-private financing |
Cell and Gene Therapy Clinical Trial Market:
| Attributes | Cell and Gene Therapy Clinical Trial Market |
|---|---|
|
CAGR (2023 to 2033) |
27.5% |
|
Market Value (2033) |
US$ 152,110 million |
|
Growth Factor |
Surge in cancer cases |
|
Opportunity |
Explicit gene modification techniques |
|
Key Trends |
Surged commercialization in cell and gene therapy |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
What Makes the United States a Large Market for Cell Therapy Manufacturing?
The United States dominates the North American region and held a total share of about 42.1% in 2022. The country is expected to continue to remain at the forefront throughout the forecast period. The increasing prevalence of sickle cell disease in the country and the presence of a large number of gene & cell and tissue-based therapeutic developers are likely to drive growth. As per the Centers for Disease Control and Prevention (CDC), sickle cell disease affects nearly 100,000 Americans and it occurs among about 1 out of every 16,300 Hispanic-American births.
What Makes the United Kingdom a Highly Lucrative Market for Cell Therapy Manufacturing?
The United Kingdom held approximately 26.6% of the Europe market in 2022. The country reflects a lucrative outlook toward cell therapy manufacturing. As per the European Medicines Agency, from 2018 until 2020, nearly 102% of advanced therapy classifications occurred across Europe annually.
What is the Outlook of China in the Cell Therapy Manufacturing Market?
China held a share of around 38.2% in 2021 in the East Asia cell therapy manufacturing market, finds FMI. Chinese local biotech businesses are working with industry associations to develop guidelines for maintaining high product quality and introducing new processing methods in an effort to streamline cell therapy manufacturing. China is likely to hold a market CAGR of 22.1% by 2033.
For instance, SALIAI, a leading stem cell start-up, is promoting the establishment of production and quality standards for the stem cell sector while collaborating with the China Quality Association for Pharmaceuticals.
Category-wise Insights
Which is the Highly Preferred Source?
The autologous source segment held the leading share of around 56.0% in 2022. Growth is attributed to various advantages of autologous sources in stem cell transplant. They help in promoting faster recovery of cell counts, reducing mortality rates associated with the treatment modality, and providing a shorter length of hospital stays.
Which is the Leading Indication Segment?
Cancer is expected to showcase high growth at a CAGR of 14.8% by the end of the forecast period. As per FMI, the segment held a market share of about 31.0% in 2022. The high incidence rate of cancer, as well as the growing adoption of novel treatment models for targeted therapy, are propelling the segment in the global cell therapy manufacturing market.
Which is the Dominant Purpose of Cell Therapy Manufacturing?
For pre-clinical, clinical, and commercial scaling of cell therapy products, manufacturing processes promote adoptive standardization for each protocol. Clinical manufacturing held a high market share of around 42.0% in the global market, followed by commercial manufacturing, which accounted for a share of about 32.0% globally in 2022.
Which Route of Administration is Set to Exhibit Lucrative Growth?
Injectables held a market share of about 44.0% in 2022 in the global market. Injectables promote greater absorption of therapeutic drugs at the target site and hence contribute to a positive outcome for disease treatment. Moreover, injections for cell therapy exhibit better cell retention at the targeted site of the disease.
Which is the Most Prominent Cell Type?
The hematopoietic stem cells (HSC) segment held a share of around 25.0% in 2022 in the cell therapy manufacturing market as many malignant disorders, including leukemia and lymphoma, as well as non-malignant conditions such as sickle cell disease, are treated with HSCs in order to replace or rebuild the patient's hematopoietic system.
Which End User Benefits the Most in the Global Market?
Hospital settings held the leading market share of around 38.1% in 2022, says FMI. This segment is emerging as a valuable end user with the advancement of point-of-care manufacturing of cell therapies in units close to hospital settings for increased accessibility of treatment, as well as to reduce treatment time and risk of contamination.
Competitive Landscape
Competitive Landscape
The global cell therapy manufacturing market is fragmented with the presence of a large number of companies. They are striving persistently to build digital capabilities for cell therapy production. These efforts help them to optimize their business processes and expand their portfolios in the global market.
For instance,
- In April 2022, Lonza added additional integrated capabilities in cell separation, bead removal, and cell binding with the release of its second-generation instrument. It helps in extending the functionality of the company’s Cocoon Platform with magnetic selection capability for cell therapy manufacturing.
- In April 2022, Catalent acquired Erytech Pharma for its industrial-scale cell therapy production plant in Princeton, New Jersey. The arrangement includes an exclusive long-term supply partnership, thereby enabling Catalent to promote red blood cell-derived therapy, eryaspase (GRASPA) by Erytech for acute lymphoblastic leukemia.
Key players
- Merck KGaA
- Avantor, Inc.
- Cell Therapies Pty Ltd
- Thermo Fisher Scientific
- Charles River Laboratories
- Catalent, Inc
- Bio-Techne
- Cytiva
- Lonza
- The Discovery Labs
- BIOCENTRIC
- FUJIFILM Diosynth Biotechnologies
- Novartis AG
- Bristol-Myers Squibb Company
- Gilead Sciences, Inc.
- WuXi AppTec.
- OXGENE
- Pharmaron
- Aldevron
- FLODESIGN SONICS
- Exothera
Key segments
By Source:
- Autologous
- Allogenic
By Indication:
- HIV
- Autoimmune Disorders
- Immune Deficiencies
- Cancer
- Neurological Disorders
By Manufacturing Purpose:
- Clinical
- Commercial
- Pre-clinical
By Route of Administration:
- Topical
- Injectable
- Infusion
- Implantable Bio-Scaffold
By Cell Type:
- Hematopoietic (Blood-Forming) Stem Cells (HSC)
- Skeletal Muscle Stem Cells
- Mesenchymal Stem Cells
- Lymphocytes
- Dendritic Cells
- Pancreatic Islet Cells
- CAR-T Cells
By End User:
- Hospital Settings
- Intensive Outpatient Treatment Centers
- Academic and Research Institutes
- Specialty Clinics
By Region :
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Frequently Asked Questions
What is the Historical Cell Therapy Manufacturing Market Share?
The cell therapy manufacturing sector expanded at a share of US$ 3,685.79 million in 2022.
Which country is set to register exponential growth in the Cell Therapy Manufacturing market?
The United States is set to register exponential growth in the cell therapy manufacturing market.
What drives sales of cell therapy manufacturing?
The increasing demand for cell therapy products and the growing number of clinical trials are expected to drive cell therapy manufacturing sales.
What key trends are driving the Cell Therapy Manufacturing Market?
The rising adoption of automation and the increasing focus on personalized medicine are key trends driving the cell therapy manufacturing market.
What opportunities await for the Market Players?
Substantial investment in research and development and expansion into new markets are expected to provide growth prospects for the market players.
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Source 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Source, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Source, 2023 to 2033 5.3.1. Autologous 5.3.2. Allogenic 5.4. Y-o-Y Growth Trend Analysis By Source, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Source, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2023 to 2033 6.3.1. HIV 6.3.2. Autoimmune Disorders 6.3.3. Immune Deficiencies 6.3.4. Cancer 6.3.5. Neurological Disorders 6.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Manufacturing Purpose 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Manufacturing Purpose, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Manufacturing Purpose, 2023 to 2033 7.3.1. Clinical 7.3.2. Commercial 7.3.3. Pre-clinical 7.4. Y-o-Y Growth Trend Analysis By Manufacturing Purpose, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Manufacturing Purpose, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Route of Administration 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By Route of Administration, 2018 to 2022 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Route of Administration, 2023 to 2033 8.3.1. Topical 8.3.2. Injectable 8.3.3. Infusion 8.3.4. Implantable Bio-Scaffold 8.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2018 to 2022 8.5. Absolute $ Opportunity Analysis By Route of Administration, 2023 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Cell Type 9.1. Introduction / Key Findings 9.2. Historical Market Size Value (US$ Million) Analysis By Cell Type, 2018 to 2022 9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Cell Type, 2023 to 2033 9.3.1. Hematopoietic (Blood-Forming) Stem Cells (HSC) 9.3.2. Skeletal Muscle Stem Cells 9.3.3. Mesenchymal Stem Cells 9.3.4. Lymphocytes 9.3.5. Dendritic Cells 9.3.6. Pancreatic Islet Cells 9.3.7. CAR-T Cells 9.4. Y-o-Y Growth Trend Analysis By Cell Type, 2018 to 2022 9.5. Absolute $ Opportunity Analysis By Cell Type, 2023 to 2033 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 10.1. Introduction / Key Findings 10.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022 10.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033 10.3.1. Hospital Settings 10.3.2. Intensive Outpatient Treatment Centers 10.3.3. Academic and Research Institutes 10.3.4. Specialty Clinics 10.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 10.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 11.1. Introduction 11.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 11.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 11.3.1. North America 11.3.2. Latin America 11.3.3. Western Europe 11.3.4. Eastern Europe 11.3.5. South Asia and Pacific 11.3.6. East Asia 11.3.7. Middle East and Africa 11.4. Market Attractiveness Analysis By Region 12. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. U.S. 12.2.1.2. Canada 12.2.2. By Source 12.2.3. By Indication 12.2.4. By Manufacturing Purpose 12.2.5. By Route of Administration 12.2.6. By Cell Type 12.2.7. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Source 12.3.3. By Indication 12.3.4. By Manufacturing Purpose 12.3.5. By Route of Administration 12.3.6. By Cell Type 12.3.7. By End User 12.4. Key Takeaways 13. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Brazil 13.2.1.2. Mexico 13.2.1.3. Rest of Latin America 13.2.2. By Source 13.2.3. By Indication 13.2.4. By Manufacturing Purpose 13.2.5. By Route of Administration 13.2.6. By Cell Type 13.2.7. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Source 13.3.3. By Indication 13.3.4. By Manufacturing Purpose 13.3.5. By Route of Administration 13.3.6. By Cell Type 13.3.7. By End User 13.4. Key Takeaways 14. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. Germany 14.2.1.2. U.K. 14.2.1.3. France 14.2.1.4. Spain 14.2.1.5. Italy 14.2.1.6. Rest of Western Europe 14.2.2. By Source 14.2.3. By Indication 14.2.4. By Manufacturing Purpose 14.2.5. By Route of Administration 14.2.6. By Cell Type 14.2.7. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Source 14.3.3. By Indication 14.3.4. By Manufacturing Purpose 14.3.5. By Route of Administration 14.3.6. By Cell Type 14.3.7. By End User 14.4. Key Takeaways 15. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. Poland 15.2.1.2. Russia 15.2.1.3. Czech Republic 15.2.1.4. Romania 15.2.1.5. Rest of Eastern Europe 15.2.2. By Source 15.2.3. By Indication 15.2.4. By Manufacturing Purpose 15.2.5. By Route of Administration 15.2.6. By Cell Type 15.2.7. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Source 15.3.3. By Indication 15.3.4. By Manufacturing Purpose 15.3.5. By Route of Administration 15.3.6. By Cell Type 15.3.7. By End User 15.4. Key Takeaways 16. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.1.1. India 16.2.1.2. Bangladesh 16.2.1.3. Australia 16.2.1.4. New Zealand 16.2.1.5. Rest of South Asia and Pacific 16.2.2. By Source 16.2.3. By Indication 16.2.4. By Manufacturing Purpose 16.2.5. By Route of Administration 16.2.6. By Cell Type 16.2.7. By End User 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Source 16.3.3. By Indication 16.3.4. By Manufacturing Purpose 16.3.5. By Route of Administration 16.3.6. By Cell Type 16.3.7. By End User 16.4. Key Takeaways 17. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 17.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 17.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 17.2.1. By Country 17.2.1.1. China 17.2.1.2. Japan 17.2.1.3. South Korea 17.2.2. By Source 17.2.3. By Indication 17.2.4. By Manufacturing Purpose 17.2.5. By Route of Administration 17.2.6. By Cell Type 17.2.7. By End User 17.3. Market Attractiveness Analysis 17.3.1. By Country 17.3.2. By Source 17.3.3. By Indication 17.3.4. By Manufacturing Purpose 17.3.5. By Route of Administration 17.3.6. By Cell Type 17.3.7. By End User 17.4. Key Takeaways 18. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 18.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 18.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 18.2.1. By Country 18.2.1.1. GCC Countries 18.2.1.2. South Africa 18.2.1.3. Israel 18.2.1.4. Rest of MEA 18.2.2. By Source 18.2.3. By Indication 18.2.4. By Manufacturing Purpose 18.2.5. By Route of Administration 18.2.6. By Cell Type 18.2.7. By End User 18.3. Market Attractiveness Analysis 18.3.1. By Country 18.3.2. By Source 18.3.3. By Indication 18.3.4. By Manufacturing Purpose 18.3.5. By Route of Administration 18.3.6. By Cell Type 18.3.7. By End User 18.4. Key Takeaways 19. Key Countries Market Analysis 19.1. USA 19.1.1. Pricing Analysis 19.1.2. Market Share Analysis, 2022 19.1.2.1. By Source 19.1.2.2. By Indication 19.1.2.3. By Manufacturing Purpose 19.1.2.4. By Route of Administration 19.1.2.5. By Cell Type 19.1.2.6. By End User 19.2. Canada 19.2.1. Pricing Analysis 19.2.2. Market Share Analysis, 2022 19.2.2.1. By Source 19.2.2.2. By Indication 19.2.2.3. By Manufacturing Purpose 19.2.2.4. By Route of Administration 19.2.2.5. By Cell Type 19.2.2.6. By End User 19.3. Brazil 19.3.1. Pricing Analysis 19.3.2. Market Share Analysis, 2022 19.3.2.1. By Source 19.3.2.2. By Indication 19.3.2.3. By Manufacturing Purpose 19.3.2.4. By Route of Administration 19.3.2.5. By Cell Type 19.3.2.6. By End User 19.4. Mexico 19.4.1. Pricing Analysis 19.4.2. Market Share Analysis, 2022 19.4.2.1. By Source 19.4.2.2. By Indication 19.4.2.3. By Manufacturing Purpose 19.4.2.4. By Route of Administration 19.4.2.5. By Cell Type 19.4.2.6. By End User 19.5. Germany 19.5.1. Pricing Analysis 19.5.2. Market Share Analysis, 2022 19.5.2.1. By Source 19.5.2.2. By Indication 19.5.2.3. By Manufacturing Purpose 19.5.2.4. By Route of Administration 19.5.2.5. By Cell Type 19.5.2.6. By End User 19.6. UK 19.6.1. Pricing Analysis 19.6.2. Market Share Analysis, 2022 19.6.2.1. By Source 19.6.2.2. By Indication 19.6.2.3. By Manufacturing Purpose 19.6.2.4. By Route of Administration 19.6.2.5. By Cell Type 19.6.2.6. By End User 19.7. France 19.7.1. Pricing Analysis 19.7.2. Market Share Analysis, 2022 19.7.2.1. By Source 19.7.2.2. By Indication 19.7.2.3. By Manufacturing Purpose 19.7.2.4. By Route of Administration 19.7.2.5. By Cell Type 19.7.2.6. By End User 19.8. Spain 19.8.1. Pricing Analysis 19.8.2. Market Share Analysis, 2022 19.8.2.1. By Source 19.8.2.2. By Indication 19.8.2.3. By Manufacturing Purpose 19.8.2.4. By Route of Administration 19.8.2.5. By Cell Type 19.8.2.6. By End User 19.9. Italy 19.9.1. Pricing Analysis 19.9.2. Market Share Analysis, 2022 19.9.2.1. By Source 19.9.2.2. By Indication 19.9.2.3. By Manufacturing Purpose 19.9.2.4. By Route of Administration 19.9.2.5. By Cell Type 19.9.2.6. By End User 19.10. Poland 19.10.1. Pricing Analysis 19.10.2. Market Share Analysis, 2022 19.10.2.1. By Source 19.10.2.2. By Indication 19.10.2.3. By Manufacturing Purpose 19.10.2.4. By Route of Administration 19.10.2.5. By Cell Type 19.10.2.6. By End User 19.11. Russia 19.11.1. Pricing Analysis 19.11.2. Market Share Analysis, 2022 19.11.2.1. By Source 19.11.2.2. By Indication 19.11.2.3. By Manufacturing Purpose 19.11.2.4. By Route of Administration 19.11.2.5. By Cell Type 19.11.2.6. By End User 19.12. Czech Republic 19.12.1. Pricing Analysis 19.12.2. Market Share Analysis, 2022 19.12.2.1. By Source 19.12.2.2. By Indication 19.12.2.3. By Manufacturing Purpose 19.12.2.4. By Route of Administration 19.12.2.5. By Cell Type 19.12.2.6. By End User 19.13. Romania 19.13.1. Pricing Analysis 19.13.2. Market Share Analysis, 2022 19.13.2.1. By Source 19.13.2.2. By Indication 19.13.2.3. By Manufacturing Purpose 19.13.2.4. By Route of Administration 19.13.2.5. By Cell Type 19.13.2.6. By End User 19.14. India 19.14.1. Pricing Analysis 19.14.2. Market Share Analysis, 2022 19.14.2.1. By Source 19.14.2.2. By Indication 19.14.2.3. By Manufacturing Purpose 19.14.2.4. By Route of Administration 19.14.2.5. By Cell Type 19.14.2.6. By End User 19.15. Bangladesh 19.15.1. Pricing Analysis 19.15.2. Market Share Analysis, 2022 19.15.2.1. By Source 19.15.2.2. By Indication 19.15.2.3. By Manufacturing Purpose 19.15.2.4. By Route of Administration 19.15.2.5. By Cell Type 19.15.2.6. By End User 19.16. Australia 19.16.1. Pricing Analysis 19.16.2. Market Share Analysis, 2022 19.16.2.1. By Source 19.16.2.2. By Indication 19.16.2.3. By Manufacturing Purpose 19.16.2.4. By Route of Administration 19.16.2.5. By Cell Type 19.16.2.6. By End User 19.17. New Zealand 19.17.1. Pricing Analysis 19.17.2. Market Share Analysis, 2022 19.17.2.1. By Source 19.17.2.2. By Indication 19.17.2.3. By Manufacturing Purpose 19.17.2.4. By Route of Administration 19.17.2.5. By Cell Type 19.17.2.6. By End User 19.18. China 19.18.1. Pricing Analysis 19.18.2. Market Share Analysis, 2022 19.18.2.1. By Source 19.18.2.2. By Indication 19.18.2.3. By Manufacturing Purpose 19.18.2.4. By Route of Administration 19.18.2.5. By Cell Type 19.18.2.6. By End User 19.19. Japan 19.19.1. Pricing Analysis 19.19.2. Market Share Analysis, 2022 19.19.2.1. By Source 19.19.2.2. By Indication 19.19.2.3. By Manufacturing Purpose 19.19.2.4. By Route of Administration 19.19.2.5. By Cell Type 19.19.2.6. By End User 19.20. South Korea 19.20.1. Pricing Analysis 19.20.2. Market Share Analysis, 2022 19.20.2.1. By Source 19.20.2.2. By Indication 19.20.2.3. By Manufacturing Purpose 19.20.2.4. By Route of Administration 19.20.2.5. By Cell Type 19.20.2.6. By End User 19.21. GCC Countries 19.21.1. Pricing Analysis 19.21.2. Market Share Analysis, 2022 19.21.2.1. By Source 19.21.2.2. By Indication 19.21.2.3. By Manufacturing Purpose 19.21.2.4. By Route of Administration 19.21.2.5. By Cell Type 19.21.2.6. By End User 19.22. South Africa 19.22.1. Pricing Analysis 19.22.2. Market Share Analysis, 2022 19.22.2.1. By Source 19.22.2.2. By Indication 19.22.2.3. By Manufacturing Purpose 19.22.2.4. By Route of Administration 19.22.2.5. By Cell Type 19.22.2.6. By End User 19.23. Israel 19.23.1. Pricing Analysis 19.23.2. Market Share Analysis, 2022 19.23.2.1. By Source 19.23.2.2. By Indication 19.23.2.3. By Manufacturing Purpose 19.23.2.4. By Route of Administration 19.23.2.5. By Cell Type 19.23.2.6. By End User 20. Market Structure Analysis 20.1. Competition Dashboard 20.2. Competition Benchmarking 20.3. Market Share Analysis of Top Players 20.3.1. By Regional 20.3.2. By Source 20.3.3. By Indication 20.3.4. By Manufacturing Purpose 20.3.5. By Route of Administration 20.3.6. By Cell Type 20.3.7. By End User 21. Competition Analysis 21.1. Competition Deep Dive 21.1.1. Merck KGaA 21.1.1.1. Overview 21.1.1.2. Product Portfolio 21.1.1.3. Profitability by Market Segments 21.1.1.4. Sales Footprint 21.1.1.5. Strategy Overview 21.1.1.5.1. Marketing Strategy 21.1.2. Avantor, Inc. 21.1.2.1. Overview 21.1.2.2. Product Portfolio 21.1.2.3. Profitability by Market Segments 21.1.2.4. Sales Footprint 21.1.2.5. Strategy Overview 21.1.2.5.1. Marketing Strategy 21.1.3. Cell Therapies Pty Ltd 21.1.3.1. Overview 21.1.3.2. Product Portfolio 21.1.3.3. Profitability by Market Segments 21.1.3.4. Sales Footprint 21.1.3.5. Strategy Overview 21.1.3.5.1. Marketing Strategy 21.1.4. Thermo Fisher Scientific 21.1.4.1. Overview 21.1.4.2. Product Portfolio 21.1.4.3. Profitability by Market Segments 21.1.4.4. Sales Footprint 21.1.4.5. Strategy Overview 21.1.4.5.1. Marketing Strategy 21.1.5. Charles River Laboratories 21.1.5.1. Overview 21.1.5.2. Product Portfolio 21.1.5.3. Profitability by Market Segments 21.1.5.4. Sales Footprint 21.1.5.5. Strategy Overview 21.1.5.5.1. Marketing Strategy 21.1.6. Catalent, Inc 21.1.6.1. Overview 21.1.6.2. Product Portfolio 21.1.6.3. Profitability by Market Segments 21.1.6.4. Sales Footprint 21.1.6.5. Strategy Overview 21.1.6.5.1. Marketing Strategy 21.1.7. Bio-Techne 21.1.7.1. Overview 21.1.7.2. Product Portfolio 21.1.7.3. Profitability by Market Segments 21.1.7.4. Sales Footprint 21.1.7.5. Strategy Overview 21.1.7.5.1. Marketing Strategy 21.1.8. Cytiva 21.1.8.1. Overview 21.1.8.2. Product Portfolio 21.1.8.3. Profitability by Market Segments 21.1.8.4. Sales Footprint 21.1.8.5. Strategy Overview 21.1.8.5.1. Marketing Strategy 21.1.9. Lonza 21.1.9.1. Overview 21.1.9.2. Product Portfolio 21.1.9.3. Profitability by Market Segments 21.1.9.4. Sales Footprint 21.1.9.5. Strategy Overview 21.1.9.5.1. Marketing Strategy 21.1.10. The Discovery Labs 21.1.10.1. Overview 21.1.10.2. Product Portfolio 21.1.10.3. Profitability by Market Segments 21.1.10.4. Sales Footprint 21.1.10.5. Strategy Overview 21.1.10.5.1. Marketing Strategy 21.1.11. BIOCENTRIQ 21.1.11.1. Overview 21.1.11.2. Product Portfolio 21.1.11.3. Profitability by Market Segments 21.1.11.4. Sales Footprint 21.1.11.5. Strategy Overview 21.1.11.5.1. Marketing Strategy 21.1.12. FUJIFILM Diosynth Biotechnologies 21.1.12.1. Overview 21.1.12.2. Product Portfolio 21.1.12.3. Profitability by Market Segments 21.1.12.4. Sales Footprint 21.1.12.5. Strategy Overview 21.1.12.5.1. Marketing Strategy 21.1.13. Novartis AG 21.1.13.1. Overview 21.1.13.2. Product Portfolio 21.1.13.3. Profitability by Market Segments 21.1.13.4. Sales Footprint 21.1.13.5. Strategy Overview 21.1.13.5.1. Marketing Strategy 21.1.14. Bristol-Myers Squibb Company 21.1.14.1. Overview 21.1.14.2. Product Portfolio 21.1.14.3. Profitability by Market Segments 21.1.14.4. Sales Footprint 21.1.14.5. Strategy Overview 21.1.14.5.1. Marketing Strategy 21.1.15. Gilead Sciences, Inc. 21.1.15.1. Overview 21.1.15.2. Product Portfolio 21.1.15.3. Profitability by Market Segments 21.1.15.4. Sales Footprint 21.1.15.5. Strategy Overview 21.1.15.5.1. Marketing Strategy 21.1.16. WuXi AppTec. 21.1.16.1. Overview 21.1.16.2. Product Portfolio 21.1.16.3. Profitability by Market Segments 21.1.16.4. Sales Footprint 21.1.16.5. Strategy Overview 21.1.16.5.1. Marketing Strategy 21.1.17. OXGENE 21.1.17.1. Overview 21.1.17.2. Product Portfolio 21.1.17.3. Profitability by Market Segments 21.1.17.4. Sales Footprint 21.1.17.5. Strategy Overview 21.1.17.5.1. Marketing Strategy 21.1.18. Pharmaron 21.1.18.1. Overview 21.1.18.2. Product Portfolio 21.1.18.3. Profitability by Market Segments 21.1.18.4. Sales Footprint 21.1.18.5. Strategy Overview 21.1.18.5.1. Marketing Strategy 21.1.19. Aldevron 21.1.19.1. Overview 21.1.19.2. Product Portfolio 21.1.19.3. Profitability by Market Segments 21.1.19.4. Sales Footprint 21.1.19.5. Strategy Overview 21.1.19.5.1. Marketing Strategy 21.1.20. FLODESIGN SONICS 21.1.20.1. Overview 21.1.20.2. Product Portfolio 21.1.20.3. Profitability by Market Segments 21.1.20.4. Sales Footprint 21.1.20.5. Strategy Overview 21.1.20.5.1. Marketing Strategy 22. Assumptions & Acronyms Used 23. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033 Table 2: Global Market Value (US$ Million) Forecast by Source, 2018 to 2033 Table 3: Global Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 4: Global Market Value (US$ Million) Forecast by Manufacturing Purpose, 2018 to 2033 Table 5: Global Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033 Table 6: Global Market Value (US$ Million) Forecast by Cell Type, 2018 to 2033 Table 7: Global Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 8: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 9: North America Market Value (US$ Million) Forecast by Source, 2018 to 2033 Table 10: North America Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 11: North America Market Value (US$ Million) Forecast by Manufacturing Purpose, 2018 to 2033 Table 12: North America Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033 Table 13: North America Market Value (US$ Million) Forecast by Cell Type, 2018 to 2033 Table 14: North America Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 15: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 16: Latin America Market Value (US$ Million) Forecast by Source, 2018 to 2033 Table 17: Latin America Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 18: Latin America Market Value (US$ Million) Forecast by Manufacturing Purpose, 2018 to 2033 Table 19: Latin America Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033 Table 20: Latin America Market Value (US$ Million) Forecast by Cell Type, 2018 to 2033 Table 21: Latin America Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 22: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 23: Western Europe Market Value (US$ Million) Forecast by Source, 2018 to 2033 Table 24: Western Europe Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 25: Western Europe Market Value (US$ Million) Forecast by Manufacturing Purpose, 2018 to 2033 Table 26: Western Europe Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033 Table 27: Western Europe Market Value (US$ Million) Forecast by Cell Type, 2018 to 2033 Table 28: Western Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 29: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 30: Eastern Europe Market Value (US$ Million) Forecast by Source, 2018 to 2033 Table 31: Eastern Europe Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 32: Eastern Europe Market Value (US$ Million) Forecast by Manufacturing Purpose, 2018 to 2033 Table 33: Eastern Europe Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033 Table 34: Eastern Europe Market Value (US$ Million) Forecast by Cell Type, 2018 to 2033 Table 35: Eastern Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 36: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 37: South Asia and Pacific Market Value (US$ Million) Forecast by Source, 2018 to 2033 Table 38: South Asia and Pacific Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 39: South Asia and Pacific Market Value (US$ Million) Forecast by Manufacturing Purpose, 2018 to 2033 Table 40: South Asia and Pacific Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033 Table 41: South Asia and Pacific Market Value (US$ Million) Forecast by Cell Type, 2018 to 2033 Table 42: South Asia and Pacific Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 43: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 44: East Asia Market Value (US$ Million) Forecast by Source, 2018 to 2033 Table 45: East Asia Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 46: East Asia Market Value (US$ Million) Forecast by Manufacturing Purpose, 2018 to 2033 Table 47: East Asia Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033 Table 48: East Asia Market Value (US$ Million) Forecast by Cell Type, 2018 to 2033 Table 49: East Asia Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 50: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 51: Middle East and Africa Market Value (US$ Million) Forecast by Source, 2018 to 2033 Table 52: Middle East and Africa Market Value (US$ Million) Forecast by Indication, 2018 to 2033 Table 53: Middle East and Africa Market Value (US$ Million) Forecast by Manufacturing Purpose, 2018 to 2033 Table 54: Middle East and Africa Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033 Table 55: Middle East and Africa Market Value (US$ Million) Forecast by Cell Type, 2018 to 2033 Table 56: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2018 to 2033
Sabyasachi Ghosh
Principal Consultant
Talk to Analyst
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Source, 2023 to 2033 Figure 2: Global Market Value (US$ Million) by Indication, 2023 to 2033 Figure 3: Global Market Value (US$ Million) by Manufacturing Purpose, 2023 to 2033 Figure 4: Global Market Value (US$ Million) by Route of Administration, 2023 to 2033 Figure 5: Global Market Value (US$ Million) by Cell Type, 2023 to 2033 Figure 6: Global Market Value (US$ Million) by End User, 2023 to 2033 Figure 7: Global Market Value (US$ Million) by Region, 2023 to 2033 Figure 8: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033 Figure 9: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 10: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 11: Global Market Value (US$ Million) Analysis by Source, 2018 to 2033 Figure 12: Global Market Value Share (%) and BPS Analysis by Source, 2023 to 2033 Figure 13: Global Market Y-o-Y Growth (%) Projections by Source, 2023 to 2033 Figure 14: Global Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 15: Global Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 16: Global Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 17: Global Market Value (US$ Million) Analysis by Manufacturing Purpose, 2018 to 2033 Figure 18: Global Market Value Share (%) and BPS Analysis by Manufacturing Purpose, 2023 to 2033 Figure 19: Global Market Y-o-Y Growth (%) Projections by Manufacturing Purpose, 2023 to 2033 Figure 20: Global Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033 Figure 21: Global Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033 Figure 22: Global Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033 Figure 23: Global Market Value (US$ Million) Analysis by Cell Type, 2018 to 2033 Figure 24: Global Market Value Share (%) and BPS Analysis by Cell Type, 2023 to 2033 Figure 25: Global Market Y-o-Y Growth (%) Projections by Cell Type, 2023 to 2033 Figure 26: Global Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 27: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 28: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 29: Global Market Attractiveness by Source, 2023 to 2033 Figure 30: Global Market Attractiveness by Indication, 2023 to 2033 Figure 31: Global Market Attractiveness by Manufacturing Purpose, 2023 to 2033 Figure 32: Global Market Attractiveness by Route of Administration, 2023 to 2033 Figure 33: Global Market Attractiveness by Cell Type, 2023 to 2033 Figure 34: Global Market Attractiveness by End User, 2023 to 2033 Figure 35: Global Market Attractiveness by Region, 2023 to 2033 Figure 36: North America Market Value (US$ Million) by Source, 2023 to 2033 Figure 37: North America Market Value (US$ Million) by Indication, 2023 to 2033 Figure 38: North America Market Value (US$ Million) by Manufacturing Purpose, 2023 to 2033 Figure 39: North America Market Value (US$ Million) by Route of Administration, 2023 to 2033 Figure 40: North America Market Value (US$ Million) by Cell Type, 2023 to 2033 Figure 41: North America Market Value (US$ Million) by End User, 2023 to 2033 Figure 42: North America Market Value (US$ Million) by Country, 2023 to 2033 Figure 43: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 44: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 45: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 46: North America Market Value (US$ Million) Analysis by Source, 2018 to 2033 Figure 47: North America Market Value Share (%) and BPS Analysis by Source, 2023 to 2033 Figure 48: North America Market Y-o-Y Growth (%) Projections by Source, 2023 to 2033 Figure 49: North America Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 50: North America Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 51: North America Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 52: North America Market Value (US$ Million) Analysis by Manufacturing Purpose, 2018 to 2033 Figure 53: North America Market Value Share (%) and BPS Analysis by Manufacturing Purpose, 2023 to 2033 Figure 54: North America Market Y-o-Y Growth (%) Projections by Manufacturing Purpose, 2023 to 2033 Figure 55: North America Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033 Figure 56: North America Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033 Figure 57: North America Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033 Figure 58: North America Market Value (US$ Million) Analysis by Cell Type, 2018 to 2033 Figure 59: North America Market Value Share (%) and BPS Analysis by Cell Type, 2023 to 2033 Figure 60: North America Market Y-o-Y Growth (%) Projections by Cell Type, 2023 to 2033 Figure 61: North America Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 62: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 63: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 64: North America Market Attractiveness by Source, 2023 to 2033 Figure 65: North America Market Attractiveness by Indication, 2023 to 2033 Figure 66: North America Market Attractiveness by Manufacturing Purpose, 2023 to 2033 Figure 67: North America Market Attractiveness by Route of Administration, 2023 to 2033 Figure 68: North America Market Attractiveness by Cell Type, 2023 to 2033 Figure 69: North America Market Attractiveness by End User, 2023 to 2033 Figure 70: North America Market Attractiveness by Country, 2023 to 2033 Figure 71: Latin America Market Value (US$ Million) by Source, 2023 to 2033 Figure 72: Latin America Market Value (US$ Million) by Indication, 2023 to 2033 Figure 73: Latin America Market Value (US$ Million) by Manufacturing Purpose, 2023 to 2033 Figure 74: Latin America Market Value (US$ Million) by Route of Administration, 2023 to 2033 Figure 75: Latin America Market Value (US$ Million) by Cell Type, 2023 to 2033 Figure 76: Latin America Market Value (US$ Million) by End User, 2023 to 2033 Figure 77: Latin America Market Value (US$ Million) by Country, 2023 to 2033 Figure 78: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 79: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 80: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 81: Latin America Market Value (US$ Million) Analysis by Source, 2018 to 2033 Figure 82: Latin America Market Value Share (%) and BPS Analysis by Source, 2023 to 2033 Figure 83: Latin America Market Y-o-Y Growth (%) Projections by Source, 2023 to 2033 Figure 84: Latin America Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 85: Latin America Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 86: Latin America Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 87: Latin America Market Value (US$ Million) Analysis by Manufacturing Purpose, 2018 to 2033 Figure 88: Latin America Market Value Share (%) and BPS Analysis by Manufacturing Purpose, 2023 to 2033 Figure 89: Latin America Market Y-o-Y Growth (%) Projections by Manufacturing Purpose, 2023 to 2033 Figure 90: Latin America Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033 Figure 91: Latin America Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033 Figure 92: Latin America Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033 Figure 93: Latin America Market Value (US$ Million) Analysis by Cell Type, 2018 to 2033 Figure 94: Latin America Market Value Share (%) and BPS Analysis by Cell Type, 2023 to 2033 Figure 95: Latin America Market Y-o-Y Growth (%) Projections by Cell Type, 2023 to 2033 Figure 96: Latin America Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 97: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 98: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 99: Latin America Market Attractiveness by Source, 2023 to 2033 Figure 100: Latin America Market Attractiveness by Indication, 2023 to 2033 Figure 101: Latin America Market Attractiveness by Manufacturing Purpose, 2023 to 2033 Figure 102: Latin America Market Attractiveness by Route of Administration, 2023 to 2033 Figure 103: Latin America Market Attractiveness by Cell Type, 2023 to 2033 Figure 104: Latin America Market Attractiveness by End User, 2023 to 2033 Figure 105: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 106: Western Europe Market Value (US$ Million) by Source, 2023 to 2033 Figure 107: Western Europe Market Value (US$ Million) by Indication, 2023 to 2033 Figure 108: Western Europe Market Value (US$ Million) by Manufacturing Purpose, 2023 to 2033 Figure 109: Western Europe Market Value (US$ Million) by Route of Administration, 2023 to 2033 Figure 110: Western Europe Market Value (US$ Million) by Cell Type, 2023 to 2033 Figure 111: Western Europe Market Value (US$ Million) by End User, 2023 to 2033 Figure 112: Western Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 113: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 114: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 115: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 116: Western Europe Market Value (US$ Million) Analysis by Source, 2018 to 2033 Figure 117: Western Europe Market Value Share (%) and BPS Analysis by Source, 2023 to 2033 Figure 118: Western Europe Market Y-o-Y Growth (%) Projections by Source, 2023 to 2033 Figure 119: Western Europe Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 120: Western Europe Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 121: Western Europe Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 122: Western Europe Market Value (US$ Million) Analysis by Manufacturing Purpose, 2018 to 2033 Figure 123: Western Europe Market Value Share (%) and BPS Analysis by Manufacturing Purpose, 2023 to 2033 Figure 124: Western Europe Market Y-o-Y Growth (%) Projections by Manufacturing Purpose, 2023 to 2033 Figure 125: Western Europe Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033 Figure 126: Western Europe Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033 Figure 127: Western Europe Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033 Figure 128: Western Europe Market Value (US$ Million) Analysis by Cell Type, 2018 to 2033 Figure 129: Western Europe Market Value Share (%) and BPS Analysis by Cell Type, 2023 to 2033 Figure 130: Western Europe Market Y-o-Y Growth (%) Projections by Cell Type, 2023 to 2033 Figure 131: Western Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 132: Western Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 133: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 134: Western Europe Market Attractiveness by Source, 2023 to 2033 Figure 135: Western Europe Market Attractiveness by Indication, 2023 to 2033 Figure 136: Western Europe Market Attractiveness by Manufacturing Purpose, 2023 to 2033 Figure 137: Western Europe Market Attractiveness by Route of Administration, 2023 to 2033 Figure 138: Western Europe Market Attractiveness by Cell Type, 2023 to 2033 Figure 139: Western Europe Market Attractiveness by End User, 2023 to 2033 Figure 140: Western Europe Market Attractiveness by Country, 2023 to 2033 Figure 141: Eastern Europe Market Value (US$ Million) by Source, 2023 to 2033 Figure 142: Eastern Europe Market Value (US$ Million) by Indication, 2023 to 2033 Figure 143: Eastern Europe Market Value (US$ Million) by Manufacturing Purpose, 2023 to 2033 Figure 144: Eastern Europe Market Value (US$ Million) by Route of Administration, 2023 to 2033 Figure 145: Eastern Europe Market Value (US$ Million) by Cell Type, 2023 to 2033 Figure 146: Eastern Europe Market Value (US$ Million) by End User, 2023 to 2033 Figure 147: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 148: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 149: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 150: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 151: Eastern Europe Market Value (US$ Million) Analysis by Source, 2018 to 2033 Figure 152: Eastern Europe Market Value Share (%) and BPS Analysis by Source, 2023 to 2033 Figure 153: Eastern Europe Market Y-o-Y Growth (%) Projections by Source, 2023 to 2033 Figure 154: Eastern Europe Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 155: Eastern Europe Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 156: Eastern Europe Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 157: Eastern Europe Market Value (US$ Million) Analysis by Manufacturing Purpose, 2018 to 2033 Figure 158: Eastern Europe Market Value Share (%) and BPS Analysis by Manufacturing Purpose, 2023 to 2033 Figure 159: Eastern Europe Market Y-o-Y Growth (%) Projections by Manufacturing Purpose, 2023 to 2033 Figure 160: Eastern Europe Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033 Figure 161: Eastern Europe Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033 Figure 162: Eastern Europe Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033 Figure 163: Eastern Europe Market Value (US$ Million) Analysis by Cell Type, 2018 to 2033 Figure 164: Eastern Europe Market Value Share (%) and BPS Analysis by Cell Type, 2023 to 2033 Figure 165: Eastern Europe Market Y-o-Y Growth (%) Projections by Cell Type, 2023 to 2033 Figure 166: Eastern Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 167: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 168: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 169: Eastern Europe Market Attractiveness by Source, 2023 to 2033 Figure 170: Eastern Europe Market Attractiveness by Indication, 2023 to 2033 Figure 171: Eastern Europe Market Attractiveness by Manufacturing Purpose, 2023 to 2033 Figure 172: Eastern Europe Market Attractiveness by Route of Administration, 2023 to 2033 Figure 173: Eastern Europe Market Attractiveness by Cell Type, 2023 to 2033 Figure 174: Eastern Europe Market Attractiveness by End User, 2023 to 2033 Figure 175: Eastern Europe Market Attractiveness by Country, 2023 to 2033 Figure 176: South Asia and Pacific Market Value (US$ Million) by Source, 2023 to 2033 Figure 177: South Asia and Pacific Market Value (US$ Million) by Indication, 2023 to 2033 Figure 178: South Asia and Pacific Market Value (US$ Million) by Manufacturing Purpose, 2023 to 2033 Figure 179: South Asia and Pacific Market Value (US$ Million) by Route of Administration, 2023 to 2033 Figure 180: South Asia and Pacific Market Value (US$ Million) by Cell Type, 2023 to 2033 Figure 181: South Asia and Pacific Market Value (US$ Million) by End User, 2023 to 2033 Figure 182: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033 Figure 183: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 184: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 185: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 186: South Asia and Pacific Market Value (US$ Million) Analysis by Source, 2018 to 2033 Figure 187: South Asia and Pacific Market Value Share (%) and BPS Analysis by Source, 2023 to 2033 Figure 188: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Source, 2023 to 2033 Figure 189: South Asia and Pacific Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 190: South Asia and Pacific Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 191: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 192: South Asia and Pacific Market Value (US$ Million) Analysis by Manufacturing Purpose, 2018 to 2033 Figure 193: South Asia and Pacific Market Value Share (%) and BPS Analysis by Manufacturing Purpose, 2023 to 2033 Figure 194: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Manufacturing Purpose, 2023 to 2033 Figure 195: South Asia and Pacific Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033 Figure 196: South Asia and Pacific Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033 Figure 197: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033 Figure 198: South Asia and Pacific Market Value (US$ Million) Analysis by Cell Type, 2018 to 2033 Figure 199: South Asia and Pacific Market Value Share (%) and BPS Analysis by Cell Type, 2023 to 2033 Figure 200: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Cell Type, 2023 to 2033 Figure 201: South Asia and Pacific Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 202: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 203: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 204: South Asia and Pacific Market Attractiveness by Source, 2023 to 2033 Figure 205: South Asia and Pacific Market Attractiveness by Indication, 2023 to 2033 Figure 206: South Asia and Pacific Market Attractiveness by Manufacturing Purpose, 2023 to 2033 Figure 207: South Asia and Pacific Market Attractiveness by Route of Administration, 2023 to 2033 Figure 208: South Asia and Pacific Market Attractiveness by Cell Type, 2023 to 2033 Figure 209: South Asia and Pacific Market Attractiveness by End User, 2023 to 2033 Figure 210: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033 Figure 211: East Asia Market Value (US$ Million) by Source, 2023 to 2033 Figure 212: East Asia Market Value (US$ Million) by Indication, 2023 to 2033 Figure 213: East Asia Market Value (US$ Million) by Manufacturing Purpose, 2023 to 2033 Figure 214: East Asia Market Value (US$ Million) by Route of Administration, 2023 to 2033 Figure 215: East Asia Market Value (US$ Million) by Cell Type, 2023 to 2033 Figure 216: East Asia Market Value (US$ Million) by End User, 2023 to 2033 Figure 217: East Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 218: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 219: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 220: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 221: East Asia Market Value (US$ Million) Analysis by Source, 2018 to 2033 Figure 222: East Asia Market Value Share (%) and BPS Analysis by Source, 2023 to 2033 Figure 223: East Asia Market Y-o-Y Growth (%) Projections by Source, 2023 to 2033 Figure 224: East Asia Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 225: East Asia Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 226: East Asia Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 227: East Asia Market Value (US$ Million) Analysis by Manufacturing Purpose, 2018 to 2033 Figure 228: East Asia Market Value Share (%) and BPS Analysis by Manufacturing Purpose, 2023 to 2033 Figure 229: East Asia Market Y-o-Y Growth (%) Projections by Manufacturing Purpose, 2023 to 2033 Figure 230: East Asia Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033 Figure 231: East Asia Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033 Figure 232: East Asia Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033 Figure 233: East Asia Market Value (US$ Million) Analysis by Cell Type, 2018 to 2033 Figure 234: East Asia Market Value Share (%) and BPS Analysis by Cell Type, 2023 to 2033 Figure 235: East Asia Market Y-o-Y Growth (%) Projections by Cell Type, 2023 to 2033 Figure 236: East Asia Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 237: East Asia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 238: East Asia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 239: East Asia Market Attractiveness by Source, 2023 to 2033 Figure 240: East Asia Market Attractiveness by Indication, 2023 to 2033 Figure 241: East Asia Market Attractiveness by Manufacturing Purpose, 2023 to 2033 Figure 242: East Asia Market Attractiveness by Route of Administration, 2023 to 2033 Figure 243: East Asia Market Attractiveness by Cell Type, 2023 to 2033 Figure 244: East Asia Market Attractiveness by End User, 2023 to 2033 Figure 245: East Asia Market Attractiveness by Country, 2023 to 2033 Figure 246: Middle East and Africa Market Value (US$ Million) by Source, 2023 to 2033 Figure 247: Middle East and Africa Market Value (US$ Million) by Indication, 2023 to 2033 Figure 248: Middle East and Africa Market Value (US$ Million) by Manufacturing Purpose, 2023 to 2033 Figure 249: Middle East and Africa Market Value (US$ Million) by Route of Administration, 2023 to 2033 Figure 250: Middle East and Africa Market Value (US$ Million) by Cell Type, 2023 to 2033 Figure 251: Middle East and Africa Market Value (US$ Million) by End User, 2023 to 2033 Figure 252: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033 Figure 253: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 254: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 255: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 256: Middle East and Africa Market Value (US$ Million) Analysis by Source, 2018 to 2033 Figure 257: Middle East and Africa Market Value Share (%) and BPS Analysis by Source, 2023 to 2033 Figure 258: Middle East and Africa Market Y-o-Y Growth (%) Projections by Source, 2023 to 2033 Figure 259: Middle East and Africa Market Value (US$ Million) Analysis by Indication, 2018 to 2033 Figure 260: Middle East and Africa Market Value Share (%) and BPS Analysis by Indication, 2023 to 2033 Figure 261: Middle East and Africa Market Y-o-Y Growth (%) Projections by Indication, 2023 to 2033 Figure 262: Middle East and Africa Market Value (US$ Million) Analysis by Manufacturing Purpose, 2018 to 2033 Figure 263: Middle East and Africa Market Value Share (%) and BPS Analysis by Manufacturing Purpose, 2023 to 2033 Figure 264: Middle East and Africa Market Y-o-Y Growth (%) Projections by Manufacturing Purpose, 2023 to 2033 Figure 265: Middle East and Africa Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033 Figure 266: Middle East and Africa Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033 Figure 267: Middle East and Africa Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033 Figure 268: Middle East and Africa Market Value (US$ Million) Analysis by Cell Type, 2018 to 2033 Figure 269: Middle East and Africa Market Value Share (%) and BPS Analysis by Cell Type, 2023 to 2033 Figure 270: Middle East and Africa Market Y-o-Y Growth (%) Projections by Cell Type, 2023 to 2033 Figure 271: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 272: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 273: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 274: Middle East and Africa Market Attractiveness by Source, 2023 to 2033 Figure 275: Middle East and Africa Market Attractiveness by Indication, 2023 to 2033 Figure 276: Middle East and Africa Market Attractiveness by Manufacturing Purpose, 2023 to 2033 Figure 277: Middle East and Africa Market Attractiveness by Route of Administration, 2023 to 2033 Figure 278: Middle East and Africa Market Attractiveness by Cell Type, 2023 to 2033 Figure 279: Middle East and Africa Market Attractiveness by End User, 2023 to 2033 Figure 280: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports
